Moreover, SIRT3 and SIRT7 have also been revealed to intermediate enzyme deacetylation, which is responsible for the reduction of ROS, leading to protection against oxidative stress-dependent developments and disorders such as cardiac hypertrophy and dysfunction, cancer, aging, and neural degeneration (64, 65). Here, SIRT3 is linked to cardiac hypertrophy.